Andrew Lo - Jun 21, 2024 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
Tryn Stimart, attorney-in-fact
Stock symbol
ABCL
Transactions as of
Jun 21, 2024
Transactions value $
$0
Form type
4
Date filed
6/24/2024, 06:19 PM
Previous filing
Jun 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share option (right to buy) Award $0 +164K +118.32% $0.00 302K Jun 21, 2024 Common Shares 164K $2.94 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.